跳至主要内容
临床试验/NCT00921934
NCT00921934已完成不适用

PASCORBIN 7.5g in the Treatment of Viral Infection, Especially Varicella Zoster Infection: An Observational Cohort Study

Pascoe Pharmazeutische Praeparate GmbH1 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2009年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
68
试验地点
1
主要终点
Change of Pain Measured by VAS

研究概览

简要总结

Chronic viral infections induce oxidative stress that can cause a number of concomitant diseases, e.g. cardio-vascular diseases or metabolic disorders. Therefore, a sufficient treatment of oxidative stress may be of benefit for the patient to prevent further diseases.

Shingles (herpes zoster infection) have been successfully treated with antioxidative substances like high-dose vitamin C for ages. Not only the acute symptoms can be diminished by high-dose vitamin C. Even long-term sequelae, like painful post-herpetic neuropathy, may be mitigated or even fully avoided.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Change of Pain Measured by VAS

时间窗: visit 1 - 3

VAS (minimum = 0 = no pain, maximum = 10 = extrem pain, change of pain measured by VAS

次要结局

未报告次要终点

研究者

发起方
Pascoe Pharmazeutische Praeparate GmbH
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验